Physicochemical properties and toxicological assessment of modified CdS nanoparticles

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2014
Editora
SPRINGER
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
SILVA, Andrea R. da
AUCELIO, Ricardo Q.
RODRIGUEZ-COTTO, Rosa I.
ORTIZ-MARTINEZ, Mario G.
RIVERA-RAMIREZ, Evasomary
FRIAS, Daniela Perroni
JIMENEZ-VELEZ, Braulio
GIODA, Adriana
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
JOURNAL OF NANOPARTICLE RESEARCH, v.16, n.10, article ID 2655, 11p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Cadmium sulfite (CdS) nanoparticles (NPs) modified with different stabilizing agents (2-mercaptopropionic acid or 2MPA, 3-mercaptopropionic acid or 3MPA, and L-cysteine or cys) were designed to be used as luminescent probes. The toxicity and inflammatory response of luminescent CdS NPs (average diameter between 2 and 3 nm) was evaluated ""in vitro"" using human lung epithelial cells (BEAS-2B). Also, mucociliary function changes or injuries were assessed by mucociliary transport (MCT) and ciliary beat frequency (CBF) measurements using frog palates. Toxicity assays showed that Cd concentrations above 1.0 mg L-1 were toxic to BEAS-2B, while Cd associated to NPs was not toxic at the concentrations tested (fivefolds that of Cd toxicity). Cadmium at toxic levels of 2.5 mg L-1 significantly induced the release of both cytokines, IL-6 and IL-8, conversely none toxic levels (2.5 mg L-1) of 2MPA-CdS nanoparticles showed similar effects. However, cys-CdS and 3MPA-CdS NPs did not induce the secretions of either IL-6 or IL-8 by lung epithelial cells at the same Cd concentration of 2.5 mg L-1. Conversely, significant reduction in the secretion of these two pro-inflammatory cytokines was observed. The MCT and CBF results revealed no impairment on mucociliary behavior except a very slight change in mucus viscosity by 3MPA-CdS NPs. These findings highlight the potential of 3MPA-CdS and cys-CdS NPs for future biomedical research, and encourage further histopathological and metabolic studies in order to strengthen that possibility.
Palavras-chave
Quantum dots, Cytotoxicity, Cytokines, Mucociliar transport, Ciliary beat frequency, Environmental and health effects
Referências
  1. Acar HY, 2009, J PHYS CHEM C, V113, P10005, DOI 10.1021/jp811104s
  2. Bansal P., 2012, RES J CHEM SCI, V2, P69
  3. Cai ZX, 2006, ANAL CHIM ACTA, V559, P234, DOI 10.1016/j.aca.2005.11.061
  4. Carvalho JM, 2013, ANAL LETT, V46, P207, DOI 10.1080/00032719.2012.704534
  5. Donaldson K, 2006, TOXICOL SCI, V92, P5, DOI 10.1093/toxsci/kfj130
  6. Donaldson K, 2002, INHAL TOXICOL, V14, P5
  7. Fuentes-Mattei E, 2010, TOXICOL APPL PHARM, V243, P381, DOI 10.1016/j.taap.2009.12.009
  8. Ghows N, 2011, ULTRASON SONOCHEM, V18, P269, DOI 10.1016/j.ultsonch.2010.06.008
  9. Gioda A, 2011, INT J ENVIRON HEAL R, V21, P106, DOI 10.1080/09603123.2010.515668
  10. HASTIE AT, 1986, CELL MOTIL CYTOSKEL, V6, P25, DOI 10.1002/cm.970060105
  11. HENGLEIN A, 1982, J PHYS CHEM-US, V86, P2291, DOI 10.1021/j100210a010
  12. Ishii H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-87
  13. Jaiganesh T, 2012, SPECTROCHIM ACTA A, V92, P29, DOI 10.1016/j.saa.2012.02.044
  14. King M, 1998, EUR RESPIR J, V11, P222, DOI 10.1183/09031936.98.11010222
  15. Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217
  16. Krupko EV, 2011, THEOR EXP CHEM+, V47, P101
  17. Kumar P, 2012, ADV MATER, V3, P471
  18. KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278
  19. Li D, 2008, SPECTROCHIM ACTA A, V71, P1204, DOI 10.1016/j.saa.2008.03.024
  20. MACCHIONE M, 1995, BRAZ J MED BIOL RES, V28, P1347
  21. Macchione M, 1999, ENVIRON HEALTH PERSP, V107, P829, DOI 10.2307/3454582
  22. Macchione M, 1998, FREE RADICAL BIO MED, V24, P714, DOI 10.1016/S0891-5849(97)00332-8
  23. Majima Y, 1999, AM J RESP CRIT CARE, V160, P421
  24. Mao YQ, 2012, ASIAN J CHEM, V24, P3715
  25. Ortiz-Martinez M, 2010, BIODIVERSITY SCI HUM, P101
  26. Park S, 2007, INHAL TOXICOL, V19, P59, DOI 10.1080/08958370701493282
  27. Petryayeva E, 2013, APPL SPECTROSC, V67, P215, DOI 10.1366/12-06948
  28. Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcnb.2006-0082SF
  29. RUBIN BK, 1990, J APPL PHYSIOL, V69, P424
  30. Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236
  31. SPANHEL L, 1987, J AM CHEM SOC, V109, P5649, DOI 10.1021/ja00253a015
  32. Trindade SHK, 2007, REV BRAS OTORRINOLAR, V73, P704, DOI 10.1590/S0034-72992007000500018
  33. Wu Weidong, 2011, ENV HLTH PERSPECT, V118, P982
  34. Yang XZ, 2008, B MATH BIOL, V70, P1192, DOI 10.1007/s11538-008-9296-3
  35. Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k
  36. Zhong WY, 2012, SPECTROSC SPECT ANAL, V32, P1570, DOI 10.3964/j.issn.1000-0593(2012)06-1570-05